Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nedaplatin and gemcitabine in recurrent/metastatic nasopharyngeal carcinoma
NCT02789189Phase 2Terminated
- Sponsor
- Sun Yat-sen University
- Start
- Jun 2016
- Primary completion
- Sep 2019
- Modality
- DNA Intercalators/Alkylators
01
Overview
A Phase 2 trial of nedaplatin in nasopharyngeal carcinoma (NPC), sponsored by Sun Yat-sen University. Started Jun 2016; status: terminated.
02
Drugs
nedaplatin
03
Conditions
nasopharyngeal carcinoma (NPC)
Beyond the preview
Go deeper on NCT02789189.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02789189.